ebook Munafa Stock Market Course + Intraday & FNO calls  

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Novo Nordisk's team in India is urging the company to launch its popular weight-loss drug, Wegovy, next year to stay ahead of rival Eli Lilly. Concerns have been raised about Novo potentially lagging behind if Wegovy is not introduced before Lilly's drug,
Announcement as on 03 December 2024

Wegovy maker Novo Nordisk bets big on talent, AI partnerships in India
Novo Nordisk is broadening its Bengaluru operations by increasing senior leadership, doubling global process leaders in India, and boosting headcount by 16% next year. The company is also collaborating with Indian AI startups to improve efficiency, particu
Announcement as on 11 October 2024

Stocks in the news: Novo Nordisk, Lilly, Deere, Levi Strauss, Starbucks and more

Announcement as on 24 September 2024

Novo Nordisk CEO spars with lawmakers over Ozempic, Wegovy prices

Announcement as on 24 September 2024

Novo Nordisk shares drop more than 4% on disappointing obesity pill data
Shares were down 4.3% at 1330 GMT, the lowest since August 8, after the company announced headline results from its trial of monlunabant, an experimental drug it acquired as part of its billion purchase of Canadian biotech company Inversago Pharmaceutic
Announcement as on 20 September 2024

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 41.09
  • 12Day Average: 40.67
  • 20Day Average: 39.97
  • 50Day Average: 40.09
  • 100Day Average: 44.01
  • 150Day Average: 43.92
  • 200Day Average: 43.12

NVO Indicators & signals

Indicator MACD (12,26,9)

40.61, 40.23, 0.15
Indicator MACD is in positive zone

Indicator ADX (14)

28.13, 37.27, 20.91
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
13 Fri Nov 2026 41.63 40.64 to 41.80 2.41% 0.87 times
12 Thu Nov 2026 40.65 40.08 to 41.01 -1.07% 1.17 times
11 Wed Nov 2026 41.09 40.10 to 41.20 0.96% 0.87 times
10 Tue Nov 2026 40.70 40.38 to 40.81 -1.64% 0.48 times
09 Mon Nov 2026 41.38 40.55 to 41.63 2.65% 0.87 times
06 Fri Nov 2026 40.31 39.53 to 40.55 0.02% 0.68 times
05 Thu Nov 2026 40.30 39.99 to 41.17 -4.46% 1.37 times
04 Wed Nov 2026 42.18 42.12 to 43.24 4.95% 1.93 times
03 Tue Nov 2026 40.19 39.96 to 40.63 -0.64% 0.91 times
02 Mon Nov 2026 40.45 40.06 to 40.78 1.1% 0.83 times
30 Fri Oct 2026 40.01 38.88 to 40.10 2.2% 0.89 times
29 Thu Oct 2026 39.15 38.56 to 39.22 2.25% 0.65 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top